BYAH investor alert cites class action over alleged IPO omissions
A PR Newswire-sponsored notice says shareholders sued Park Ha Biological Technology Co., Ltd. over alleged IPO disclosure omissions tied to a 93% one-day share drop.
A PR Newswire investor alert says a securities class action was filed over Park Ha Biological Technology Co., Ltd., alleging IPO disclosures failed to reveal an active promotional scheme before a sharp stock drop.
A PR Newswire release issued by SueWallSt, on behalf of Levi & Korsinsky LLP, says a securities class action has been filed against Park Ha Biological Technology Co., Ltd. in the U.S. District Court for the Southern District of New York.
The notice says the case concerns purchasers of Park Ha Biological Technology shares between Dec. 27, 2024, and July 8, 2025. It says the lead plaintiff deadline is Sept. 28, 2026.
The alert says BYAH shares fell about 93% on July 8, 2025, dropping $38.02 from the prior close to $2.99 on volume above 8.9 million shares. It says the move erased more than $1 billion in market value.
The notice says the lawsuit centers on alleged omissions in the company’s IPO prospectus and SEC filings. It quotes risk-factor language warning that low-float IPO stocks can see extreme run-ups, rapid price declines, low trading volume and wide bid-ask spreads, and that such moves may be unrelated to operating performance.
According to the alert, plaintiffs argue that language was hypothetical and did not disclose what they describe as an active promotional scheme already affecting the stock.
The notice says the alleged scheme involved impersonators using stolen identities of real financial advisors who directed retail investors into WhatsApp groups and told them to buy BYAH beginning June 18, 2025. It says the promotion cited a fabricated L'Oréal partnership and promised a 200% to 300% increase in the share price.
The release says the action asserts claims under Sections 11, 12 and 15 of the Securities Act and Sections 10(b) and 20(a) of the Exchange Act. As a legal-advertising investor alert rather than a court docket, the allegations in the notice should be treated as claims made by the issuer of the release.
The notice does not include a response from Park Ha Biological Technology.
The lead plaintiff deadline is in September 2026. Investors who believe they qualify are directed in the notice to contact the plaintiffs’ lawyers listed in the release.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
Comments ()